Skip to main content

Table 3 Cumulative disease activity, quality of life, treatment and persistence between cases and paired controls (Restricted*)

From: Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritis

 

Patients with HDO, N = 26

Patients with continuous follow-up, N = 52

p-value

Cumulativea disease activity and function

 DAS28

2.8 (1.5–3.2)

1.7 (1.2–2.2)

0.004

 N° of flares/patient

1 (1–2)

0 (0–1)

0.000

 N° (%) of patients with sustained remission at outcome

17 (65.4)

48 (92.3)

0.007

 SF36 score

86 (70.6–91.8)

89.3 (81.1–92)

0.12

N° of schedule visits

4 (3–4)

3 (3–4)

0.02

Cumulativea treatment

 N° (%) of patients on corticosteroids

9 (34.6)

23 (44.2)

0.47

 N° of DMARD/patient

1 (1–2)

1 (1–1)

0.10

Cumulativea patient’s treatment behavior

 % of follow-up on persistence

82.9 (45–100)

84.5 (65–100)

0.38

 N° (%) of patients with persistence <50%

7 (26.9)

6 (11.5)

0.11

 N° (%) of patients recurrent non-persistent

8 (30.8)

19 (36.5)

0.8

  1. Data presented as median (Q25-Q75) unless otherwise indicated
  2. aRestricted to the year previous to HDO (or equivalent among the controls)